The "dormant" status only applies to Parallel Distribution Regulatory entitlements. Please see below the information from the Parallel Distribution FAQs. 

If the medicinal product has not been distributed in parallel for the last 12 months it should be updated to the ‘dormant’ status using the ‘update of parallel distribution notice status’ procedure, which does not incur any fees. During the period of dormancy the annual update does not need to be submitted.

The confirmed dormancy will be reflected in the public register of parallel distribution.  An independent notice will not be sent.

The product will remain ‘dormant’ until the Agency is notified otherwise. To resume distribution of the product after a period of ‘dormancy’, an ‘annual update’ should be submitted.